stock
PALI · PALISADE BIO, INC.
What PALISADE BIO, INC. reports to the SEC, read from its filings.
Open in the appPrice
The live PALI price and today's change.
Sign in to see thisChart
Thirty days of daily bars, with signal levels drawn on them.
Sign in to see thisSignals
The latest signal group Nakagai's scanner recorded on PALI.
Sign in to see thisOptions positioning
Gamma exposure levels from the options market.
Sign in to see thisTechnicals
Trend, momentum and volatility gauges per timeframe.
Sign in to see thisWhat it is
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Filer (SEC EDGAR)
- EDGAR filing index
- Shares outstanding
- 174,270,558 as of 2026-08-06 (XBRL frame CY2026Q2I)
Key stats
Valuation
- P/E
- Locked
- P/S
- Locked
- P/B
- Locked
- Enterprise value
- Locked
- EV/EBIT
- Locked
- FCF yield
- Locked
Margins
- Gross
- —
- Operating
- -7069.8%
- Net
- -6388.2%
Returns
- ROE
- -26.2%
- ROA
- -25.1%
Health
- Current ratio
- 24.3x
- Debt/equity
- —
Deep value
- NCAV
- $121.69M
- NCAV per share
- $0.70
- Price/NCAV
- Locked
- NNWC
- $119.98M
- NNWC per share
- $0.69
- Price/NNWC
- Locked
Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.
Sign in to see thisDebt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.
Results
| Period end | Revenue | Gross profit (not reported by this company) | Operating income | Net income | Filing |
|---|---|---|---|---|---|
| 2026-06-30 | $500,000 | —Gross profit: unreported by this company. | -$11.70M | -$10.57M | 10-Q filed 2026-08-10 |
| 2026-03-31 | $0 | —Gross profit: unreported by this company. | -$10.75M | -$9.60M | 10-Q filed 2026-05-12 |
| 2025-12-31 | $0 | —Gross profit: unreported by this company. | -$9.98M | -$8.90M | DEF 14A filed 2026-04-29 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-09-30 | $0 | —Gross profit: unreported by this company. | -$2.92M | -$2.87M | 10-Q filed 2025-11-10 |
| 2025-06-30 | $0 | —Gross profit: unreported by this company. | -$2.84M | -$2.78M | 10-Q filed 2026-08-10 |
| 2025-03-31 | $0 | —Gross profit: unreported by this company. | -$2.31M | -$2.23M | 10-Q filed 2026-05-12 |
| 2024-12-31 | $0 | —Gross profit: unreported by this company. | -$3.38M | -$3.34M | DEF 14A filed 2026-04-29 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. Assembled from more than one filing; the filing above is only the newest of them. |
| 2024-09-30 | $0 | —Gross profit: unreported by this company. | -$3.59M | -$3.49M | 10-Q filed 2025-11-10 Assembled from more than one filing; the filing above is only the newest of them. |
- Assets
- $127.31M
- Equity
- $121.75M
Balance as of 2026-06-30.
Ten years
| Fiscal year end | Revenue | Operating income | Net income | Free cash flow |
|---|---|---|---|---|
| 2025-12-31 | $0 | -$18.06M | -$16.78M | — |
| 2024-12-31 | $0 | -$14.86M | -$14.44M | -$12.19M |
| 2023-12-31 | $250,000 | -$13.07M | -$12.30M | -$11.14M |
| 2022-12-31 | $0 | -$15.72M | -$14.26M | -$13.37M |
| 2021-12-31 | — | -$41.85M | -$26.62M | -$14.77M |
| 2020-12-31 | $13,520 | -$9.30M | -$10.32M | -$4.77M |
| 2019-12-31 | $15,394 | -$8.63M | -$8.35M | — |
| 2018-12-31 | $260,000 | -$8.26M | -$4.92M | -$7.69M |
| 2017-12-31 | $260,000 | -$13.31M | -$15.67M | -$13.43M |
| 2016-12-31 | $16,246 | -$20.64M | -$21.07M | -$15.71M |
Company filings
since Tue May 12
events
Results
ResultsAug 108-KExecutive or director change, Bylaws or fiscal year change, Shareholder vote results
Executive or director changeBylaws or fiscal year changeShareholder vote resultsJun 118-KResults
ResultsMay 128-KOther event
Other eventApr 28-KBylaws or fiscal year change, Shareholder vote results
Bylaws or fiscal year changeShareholder vote results12/4/20258-KExecutive or director change
Executive or director change10/22/20258-K
5% owners ()
Commodore Capital LP
Stake update
Soleus Capital Master Fund, L.P.
Stake update
BlackRock, Inc.
Passive stake
Soleus Capital Master Fund, L.P.
Passive stake
RA Capital Management, L.P.
Stake update
Insiders, politicians and funds
Insider trades, last 90 days
Williams Donald Allen
Director
Buy$28,800Oct 5, 5:20 PM ET
Baltera Robert Jr.
Director
Buy$88,698Jul 10, 6:14 PM ET
Baltera Robert Jr.
Director
Buy$102,084Jul 8, 6:56 PM ET
Jones Mitchell Lawrence
Chief Medical Officer
Sale$106,536Jul 8, 6:52 PM ET
Finley John David
CEO, CFO, Director
Sale$303,343Jul 8, 6:49 PM ET
Politician trades, last 90 days
No politician trades filed in the last 90 days.
News
Stories that named PALI, and the market events around them.
Sign in to see thisBoard
Recent signals
Signals open up here once a member has posted about PALI.
Signals are informational.
Posts · 0
No posts yet.
nakagai
Signals on PALI come from a rule, not a model.
Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.
Members post on the PALI board